Cardiovascular and biological effects of K+ channel openers, a class of drugs with vasorelaxant and cardioprotective properties
- 31 December 1990
- journal article
- review article
- Published by Elsevier in Life Sciences
- Vol. 47 (19), 1693-1705
- https://doi.org/10.1016/0024-3205(90)90342-o
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- BRL 34915 Ameliorates Oxygen Supply in Ischemic Myocardium by a Simultaneous Enhancement of Coronary Blood Flow and a Reduction of Myocardial functionJournal of Cardiovascular Pharmacology, 1990
- Profibrillatory Actions of Pinacidil in a Conscious Canine Model of Sudden Coronary DeathJournal of Cardiovascular Pharmacology, 1990
- Differential systemic and regional hemodynamic profiles of four angiotensin-I converting-enzyme inhibitors in the ratCardiovascular Drugs and Therapy, 1989
- Effects of nicorandil on coronary circulation and myocardial ischemiaThe American Journal of Cardiology, 1989
- Nicorandil as a hybrid between nitrates and potassium channel activatorsThe American Journal of Cardiology, 1989
- The Haemodynamic Profile of Cromakalim in the CatJournal of Cardiovascular Pharmacology, 1988
- The potassium channel opener cromakalim (BRL 34915) activates ATP-dependent K+ channels in isolated cardiac myocytesBiochemical and Biophysical Research Communications, 1988
- Electrophysiological and antiarrhythmic effects of the K-channel opener, BRL 34915, in cardiac purkinje fibersDrug Development Research, 1988
- Intracellular control of renin release — An overviewKlinische Wochenschrift, 1986
- Suppression of Ventricular Arrhythmias After Coronary Artery Ligation by Pinacidil, a Vasodilator DrugJournal of Cardiovascular Pharmacology, 1985